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Abstract
The antidiabetic effect of an aqueous seed
extract of Syzygium calophyllifolium
Walp.was studied in alloxan induced
diabetic rats. Changes in serum and tissue
AST, ALT LDH, ACP and ALP, enzymes
activities in alloxan induced rats were
studied and found to be reversed by the oral
administration of S.calophyllifolium seed
extract.
Introduction
Diabetes is a group of related diseases, all
of which are characterized by
hyperglycemia secondary to deranged
secretion or action of insulin. The
concentration of glucose in blood depends
on insulin production and utilization in
normal as well as in diabetic condition by
different tissues 1.  Absence of insulin effect
leads to glucose over production and under
utilization by liver. However the insulin
dependent tissues such as kidney show over
utilization of glucose during diabetes
because of hyperglycemia 2.
Hyperglycemia directly contributes to the
complications through increased
glycosylation leading to biochemical and
morphological abnormalities due to altered
protein structure 3.  Diabetes complications
include thickening of the capillary
basement membranes, retinopathy and
nephropathy. If diabetes is left untreated it
almost develops into complications such
as irreversible hepatic and renal
deterioration 4.
Insulin fails to prevent the serious vascular
and other complications of diabetes inspite
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of  effective control of diabetic symptoms.
Thus, there is a need to seek newer and
alternative approaches for effective therapy
in diabetes management. Traditional
medicine such as Ayurveda and Unani in
India and other countries since ancient days
have employed hypoglycemic plants 5. The
present study investigates the antidiabetic
property of S.calophyllifolium seed extract
in alloxan induced rats which was assessed
by measuring the levels of tissue and serum
marker enzymes.
Materials and methods :
Plant material and preparation of
plant extract
S. calophyllifolium, fruits were collected
from Ooty, Nilgris District, Tamilnadu, India6.
They were identified and authenticated by
Department of Botany, Kongunadu Arts and
Science College, Coimbatore. The seeds
were separated from the fruits and shadow
dried in laboratory at room temperature and
powdered in a mixer grinder.
Aqueous extract was prepared by taking
100g of seed power and added 500ml of
distilled water and heated for 3 hours below
50ÚC. The extract was filtered with
Whatmann No.2 filter paper. The filtrate was
used for the oral administration.
Selection of animals
Male albino rats weighing at an average of
150-200g were obtained from the Vetinary
College, Thrissur, Kerala were used for the
study. They animals were fed with standard
pelleted diet from Hindustan Lever Ltd.,
Bangalore, India and water ad libitum. The
pellet composition was found to be similar
to RDA (Recommended Dietary
Allowances) for laboratory animals.
Experimental induction of diabetes
mellitus
The rats were injected intraperitonialy with
alloxan monohydarte dissolved in sterile
saline at dose level of 80 mg/Kg body
weights. After two weeks rats with moderate
diabetes having glycosuria (indicated by
benedict’s qualitative test) and
hyperglycemia (i.e with a blood glucose of
200-300 mg/ dl) were used for the
experiment 7.
Experimental setup
Rats were divided in to four groups
comprising of six animals each groups as
follows.
Group I : Control group fed with
normal diet.
Group II : Toxic group animals induced
with alloxan monohydrate
Group III : Diabetic rats treated with
herbal drug 1.0 ml /rat/day,
orally for 30 days and
Group IV : Control animal treated with
herbal drug 1.0ml/rat/day,
orally for 30 days.
Collection of rat serum, liver and kidney
samples
After the experimental regimen the animals
were sacrificed under mild chloroform
anesthesia. Blood was collected and serum was
separated by centrifugation for 20 min. at 2000
rpm. The liver and kidney were excised
immediately, washed with cold saline.
Preparation of tissue homogenate
The liver was cut into small pieces. A 10%
homogenate of liver and kidney tissues were
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prepared by using 0.1M Tris HCl buffer (pH
7.4).  This serum and total tissue
homogenate were then subjected to
biochemical analysis.
 Biochemical stuides
Aminotransferase were estimated by the
method Reitmann and Frankel (1957) 8. Acid
and alkaline phosphatase were estimated by
King and Amstrong (1934)9. Lactate
dehydrogenate was estimated by King
(1965)10.
Statistics
The results were expressed as mean ± S.D
and the data obtained were analyzed by one-
way analysis of variance (ANOVA). The
significant difference between the means of
treated and untreated groups estimated by
Duncan’s Multiple Range Test (DMRT).
P<0.05 was considered significant.
Results
Effect of aqueous extrat of S.calophy-
llifolium on serum marker enzymes such as
Aspartate transaminase (AST), alanine
transaminase (ALT), lactate dehydrogenase
(LDH) acid phosphatase (ACP) and alkaline
phosphatase (ALP) of control and
experimental rats shown in table 1.
The level of all the enzymes in serum were
markedly elevated in alloxan induced
diabetic rats when compared with control.
Oral administration of S.calophyllifolium
seed extracts for 30 days brought back to
the activity of the above enzymes to near
normal levels. However herbal drug alone
treated rats did not show any significant
changes when compared with control
(Group IV).
Table 2 and 3 show the levels of marker
enzymes in liver and kidney of control and
experimental animals. Significant
elevations in liver marker enzyme were
observed in diabetic rats when compared
with control rats. Oral administration of
S.calophyllifolium reversed these enzymes
to near normal value. Rats administered
with S.calophyllifolium alone treated did
not produce any significant alteration in
liver marker enzymes.
 Discussion
Diabetes mellitus (DM) is an endocrine
disorder in which glucose metabolism is
impaired because of total loss of insulin
after destruction of pancreatic beta cells
(type I diabetes mellitus or IDDM) or
because of inadequate release of insulin
from the pancreatic beta cells or
insentitivity of target tissue to insulin (type
II diabetes mellitus or NIDDM). Alloxan is
a valuable agent for the experimental
production of diabetes. The user of lower
dose of Alloxan (80mg/dl) produced an
incomplete destruction of pancreatic beta
cells even though rats become permanently
diabetic 11.
A marked increased in the activities of AST,
ALT, and LDH in serum and tissues of
group II rats indicates injury caused in
tissues. When cell membrane gets damaged
these enzymes which are normally located
in the cytosol leak in to the blood stream
thus manifesting damage effected to liver
and other tissues. The attainment of near
normalcy was observed in the activities of
AST, ALT, and LDH in S.calophyllifolium
administered group III rats 12.
Acid phosphatase and alkaline phosphatase
are frequently employed as marker enzymes
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to assess the lysosomal changes in vivo
because it is localized almost exclusively in
the particles and its release parallels that of
lysosomal hydrolases. A significant reduction
in these phosphatases as a result of
S.calophyllifolium treatment against alloxan
induced diabetes indicates protection against
the rupture of lysosomal and the leakage of
these enzymes. These altered biochemical
profiles due to Alloxan induced diabetes were
significantly reversed towards normalization
by the treatment with S.calophyllifolium
aqueous seed extract.
Table 1
Effect of S. calophyllifolium on marker enzyme in serum of control and
alloxan induced diabetic rats.
In conclusion the result of the present study
demonstrates that S.calophyllifolium seed
extract has potent antidiabetic activity
against alloxan induced rats. The result also
implies that the antidiabeteic effect of
S.calophyllifolium may be due to it
secondary metabolites.
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Parameters  Group I  Group II  Group III  Group IV 
AST  44.51±3.52 74.53±3.20  a* 48.44±2.53b* 43.38±3.56  c
ns 
ALT  98.46±7.73 199.22±12.09a*  105.33±7.42b* 97.67±6.56  c
ns 
LDH  109.11±6.82 143.50±8.17a* 124.98±8.42b*  104.02±8.68  c
ns 
ACP  56.05±2.38 72.63±2.37a* 60.59±2.11b* 54.55±1.87  c
ns 
ALP  65.54±3.75 163.68±3.93a* 80.99±5.43b* 63.88±3.60  c
ns 
 
Values are expressed as mean ± SD of six animals (n = 6)
Statistical comparison
  a:  group I and group II
  b: group II and group III
  cns: group I and group IV
Statistical significance: * p <0.05, ns – not significant
Units:
AST, ALT, LDH, ACP and ALP – IU/L.
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Table 2 : Effect of S. calophyllifolium on marker enzyme in liver of
control and alloxan induced diabetic rats
Parameters  Group I  Group II  Group III  Group IV 
AST  6.34±0.16  15.16±0.92 a*  8.06±0.52b*  5.79±0.52 c
ns 
ALT  8.48±0.67 24.77±1.46a*  13.30±0.97b*  7.74±0.75  c
ns 
LDH  50.13±0.81 123.19±4.33a* 87.78±2.90b* 46.99±1.93  c
ns 
ACP  18.87±0.83 30.17±1.29a* 20.59±0.64b*  18.13±0.56  c
ns 
ALP  15.30±0.18 31.03±0.82a* 17.78±0.34b*  14.34±0.28  c
ns 
 
Values are expressed as mean ± SD of six animals (n = 6)
Statistical Comparison
  a:  group I and group II
  b: group II and group III
  cns: group I and group IV
Statistical significance: * p <0.05, ns – not significant
Units : AST, ALT, LDH, ACP and ALP – IU/L.
Table 3 : Effect of S. calophyllifolium on marker enzyme in kidney of
control and alloxan induced diabetic rats
Parameters  Group I  Group II  Group III  Group IV 
AST  7.28±0.65 15.26±0.89  a* 8.96±0.41b*  6.81±0.57  c
ns 
ALT  6.31±0.18 21.46±2.01a* 8.28±0.62b* 5.83±0.35  c
ns 
LDH  29.84±0.94 66.05±1.77a* 34.99±1.31b* 30.03±1.43  c
ns 
ACP  16.45±0.33 32.14±0.85a* 18.08±0.27b* 15.69±0.20  c
ns 
ALP  15.81±0.34 30.52±0.96a* 17.94±0.36b* 15.60±0.81  c
ns 
 
Values are expressed as mean ± SD of six animals (n = 6)
Statistical Comparison
  a:  group I and group II
  b: group II and group III
  cns: group I and group IV
Statistical significance: * p <0.05, ns – not significant
Units : AST, ALT, LDH, ACP and ALP – IU/L.
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